Robert Grant brings his tremendous experience in innovation and dynamic growth for Fortune 500 companies to his role as CEO of ALPHAEON. For over 20 years, he has played a pivotal role in successful technology and business development in pharmaceutical, medical device, and healthcare markets.
Most recently, he was CEO and President of Bausch+Lomb Surgical, leading the significant growth of their product portfolio. In 2006-2010, Mr. Grant was President of Allergan Medical, leading the $3.2 billion Inamed acquisition and the commercial success of Botox Cosmetic, Juvederm, Natrelle bresast implants, and Lap-Band brands. Beginning in 2003, Mr. Grant served as Director, Chairman of the Board, CEO, President, COO, and CFO of Biolase Technology. From 1997-2003, he held various senior management positions at Lumenis.
Mr. Grant has served on several corporate boards as an independent director including Acufocus, Myoscience, and ReShape. Additionally, he has served on several community and civil boards including Make-A-Wish Foundation, Young Presidents Organization, UCI CEO Roundtable Steering Committee, Chapman Schmid College, The Henry Samueli School of Engineering at UCI, and the law school at the same university.
Mr. Grant holds a BA from Brigham Young University and an MBA with Honors from Thunderbird School of Global Management. He has also attended the President’s Seminar at Harvard Business School. He has lived and worked in nine countries and speaks Japanese, French, Korean, and German fluently.
Educators in Papillion La Vista Community Schools received nearly $39,000 in grants to help fund projects that bring additional opportunities to students.Read More
Together with Papillion La Vista Community Schools, the Papillion-La Vista Schools Foundation works to recognize those staff members who go above and beyond through an annual awards ceremony. Nominate a deserving individual for a Greatness Award!Read More